Acadia Pharmaceuticals Inc (ACAD)
Working Capital Ratio
49.52%
Quarterly · Period ending:
ACAD Working Capital Ratio
Latest reported49.52%period ending
Latest reported49.52%period ending
ACAD Quarterly Working Capital Ratio (63.25% → 49.52%)
Quarterly working capital ratio
High-resolution chart · PNG
ACAD working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 49.5214% | |
| 49.2448% | |
| 50.1855% | |
| 54.0918% | |
| 51.4484% | |
| 50.1969% | |
| 45.7542% | |
| 45.4861% | |
| 42.7815% | |
| 40.3108% | |
| 48.3167% | |
| 45.7784% | |
| 47.4021% | |
| 42.5068% | |
| 65.039% | |
| 67.2179% | |
| 67.6993% | |
| 67.7003% | |
| 74.5234% | |
| 77.0127% | |
| 75.9774% | |
| 74.7658% | |
| 78.1544% | |
| 80.2295% | |
| 85.4754% | |
| 83.5748% | |
| 87.5177% | |
| 88.1137% | |
| 80.9589% | |
| 80.1076% | |
| 86.3642% | |
| 79.6788% | |
| 79.9727% | |
| 83.7298% | |
| 84.3802% | |
| 88.4256% | |
| 88.2794% | |
| 88.3651% | |
| 90.0489% | |
| 91.4084% | |
| 90.1471% | |
| 94.5648% | |
| 88.8195% | |
| 91.7626% | |
| 92.1884% | |
| 93.8022% | |
| 94.8768% | |
| 96.5031% | |
| 97.232% | |
| 97.6656% | |
| 95.9089% | |
| 95.7448% | |
| 96.1703% | |
| 94.4426% | |
| 94.4838% | |
| 74.1011% | |
| 68.6431% | |
| 75.2442% | |
| 80.289% | |
| 81.9891% | |
| 84.8919% | |
| 86.1838% | |
| 83.0599% | |
| 61.0462% | |
| 64.6837% | |
| 66.3624% | |
| 67.967% | |
| 71.0663% | |
| 67.4793% | |
| 73.1592% | |
| 79.3652% | |
| 82.2641% | |
| 82.45% | |
| 85.328% | |
| 83.1941% | |
| 86.1473% | |
| 88.9815% | |
| 72.732% | |
| 72.8681% | |
| 76.3393% | |
| 75.5875% | |
| 61.995% | |
| 61.4716% | |
| 68.7491% | |
| 81.9231% | |
| 69.593% | |
| 72.2842% | |
| 74.433% | |
| 76.3415% | |
| 48.3243% | |
| 63.2515% |